Pharming (PHAR) Current Leases (2019 - 2026)

Pharming's Current Leases history runs 8 years deep, the most recent figure standing at $14.7 million for Q1 2026.

• Quarterly Current Leases fell 44.65% year-over-year to $14.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.7 million (down 44.65% YoY) and the FY2025 annual result came in at $14.4 million, up 387.14% from the prior year.
• Current Leases was $14.7 million for Q1 2026 at Pharming, up from $14.4 million in the prior quarter.
• Across five years, Current Leases topped out at $31.1 million in Q1 2023 and bottomed at $15227.0 in Q3 2022.
• A 5-year average of $19.4 million and a median of $26.5 million in 2025 frame the typical range for Current Leases.
• Peak annual rise in Current Leases reached 231046.69% in 2022, while the deepest fall reached 99.92% in 2022.
• Pharming's Current Leases stood at $3.5 million in 2022, then gained by 4.36% to $3.6 million in 2023, then retreated by 18.53% to $2.9 million in 2024, then jumped by 387.14% to $14.4 million in 2025, then grew by 2.22% to $14.7 million in 2026.
• Business Quant data shows PHAR's Current Leases at $14.7 million in Q1 2026, $14.4 million in Q4 2025, and $28.1 million in Q3 2025.